Estimating the long term cost savings from the treatment of Alzheimer's disease: A modelling approach

被引：2
|
作者：
Neumann, PJ [1 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源：
PHARMACOECONOMICS | 2000年 / 17卷 / 01期
关键词：
Public Health; Adverse Effect; Health Outcome; Nursing Home; Drug Therapy;
D O I：
10.2165/00019053-200017010-00007
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] Estimating the Long Term Cost Savings from the Treatment of Alzheimer’s Disease: A Modelling Approach
    Peter J. Neumann
    PharmacoEconomics, 2000, 17 : 109 - 109
  • [2] Estimating long term cost savings from treatment of Alzheimer's disease - A modelling approach
    Fenn, P
    Gray, A
    PHARMACOECONOMICS, 1999, 16 (02) : 165 - 174
  • [3] Estimating Long Term Cost Savings from Treatment of Alzheimer’s DiseaseA Modelling Approach
    Paul Fenn
    Alastair Gray
    PharmacoEconomics, 1999, 16 : 165 - 174
  • [4] Potential savings in the cost of caring for Alzheimer's disease - Treatment with rivastigmine
    Hauber, AB
    Gnanasakthy, A
    Snyder, EH
    Bala, MV
    Richter, A
    Mauskopf, JA
    PHARMACOECONOMICS, 2000, 17 (04) : 351 - 360
  • [5] Potential savings in the cost of caring for Alzheimer's disease treatment with rivastigmine
    Linkins, KW
    Lloyd, LR
    Hjelmstad, GO
    Strausbaugh, HJ
    PHARMACOECONOMICS, 2000, 18 (06) : 609 - 610
  • [6] Potential savings in the cost of caring for Alzheimer's disease: Treatment with rivastigmine
    Hauber A.B.
    Gnanasakthy A.
    Snyder E.H.
    Bala M.V.
    Richter A.
    Mauskopf J.A.
    PharmacoEconomics, 2000, 17 (4) : 351 - 360
  • [7] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease
    Stefan J. Teipel
    Michael Ewers
    Veronika Reisig
    Bernd Schweikert
    Harald Hampel
    Michael Happich
    European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 330 - 336
  • [8] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease
    Teipel, Stefan J.
    Ewers, Michael
    Reisig, Veronika
    Schweikert, Bernd
    Hampel, Harald
    Happich, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (06) : 330 - 336
  • [9] Potential savings in the cost of caring for Alzheimer's disease treatment with rivastigmine - Reply
    Hauber, AB
    Mauskopf, JA
    Snyder, EH
    PHARMACOECONOMICS, 2000, 18 (06) : 610 - 612
  • [10] Savings in the cost of caring for patients with Alzheimer's disease in Canada: An analysis of treatment with rivastigmine
    Hauber, AB
    Gnanasakthy, A
    Mauskopf, JA
    CLINICAL THERAPEUTICS, 2000, 22 (04) : 439 - 451
12345